Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Non-clarithromycin Triple Therapy for H. pylori Eradication
NCT02776371Phase 4Completed
- Sponsor
- Shandong University
- Start
- Sep 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rabeprazole, amoxicillin, tinidazole in Helicobacter pylori infection, sponsored by Shandong University. Started Sep 2016; status: completed.
02
Drugs
rabeprazoleamoxicillintinidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02776371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02776371.